Medicine
KADCYLA 160
Key ingredient(s)
0 Mg
Trastuzumab Emitansine
Trastuzumab Emtansine 160
Available forms & strengths
Request this medicine| Form | Strength | Pack | Route | Icon |
|---|---|---|---|---|
| POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION | 160,0 mg | — | Parenteral |
|
Notes: SAHPRA secureId: CfDJ8L67LitnFgdOq0Uv0zyh2bp0iaSgTFlNPKO24e0i7KTfQwdOkokJtjSLA3eBtDF-Sgqb5WptP0_KrL36zAAgf-AVlrwg0t07wvtRSA5df0qgvqCyYFBXkJIr4-i1ly4Byg | Reg: 49/32.16/0198 | AppNo: 490198 | RegDate: 2019/06/26 | Applicant: Roche Products (Pty) Ltd | API: Trastuzumab Emitansine | Status: Registered